Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy

Nature Medicine has issued a publisher correction to a paper on molecular predictors of minimal residual disease in newly diagnosed multiple myeloma patients treated with quadruplet therapy. No further details of the correction are provided.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.